Welcome

Celebrating 80 Years Of Service!

The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.

"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."

ADVOCACY UPDATES

Changes To E/M Codes Beginning On January 1st

Effective January 1, 2021, the Centers for Medicare & Medicaid (CMS) finalized significant changes to…

read more

Additional COVID-19 Relief Up in the Air

House Speaker Nancy Pelosi (D-CA) and Treasury Secretary Steven Mnuchin appeared to be moving closer…

read more

CY 2021 Physician Fee Schedule Proposed Rule Summary

On August 3, the Centers for Medicare & Medicaid Services (CMS) released the Medicare Physician…

read more

Changes in MACRA

Macra 101 Image

Before the close of 2017, all physicians must take action to avoid the 4 percent cut that will be assessed in 2019 for not participating in the new Quality Payment Program (QPP) authorized by the Medicare Access and CHIP Reauthorization Act (MACRA).  Read More

CMS Announces Changes in MACRA Implementation Timeline. The Centers for Medicare and Medicaid Services (CMS) announced major changes to the implementation of the Medicare Access and CHIP Re-authorization (MACRA).
Read More

Upcoming Dates

02/01/20: 2021 Annual Meeting Crowdsourcing
Learn more

01/15/2021: Call for Proposals
Learn more

04/01/21: Fellow Exam Application Deadline
Learn more

06/01/21: Research Grant Cycle
Learn more

06/26/21: Membership Application Deadline to be eligible for AAOA Member rate for the 2021 Basic Course

07/15/21: Call for Scientific Papers

09/01/21: Membership Application Deadline to be voted in at the 2021 Annual Meeting

12/01/21: Research Grant Cycle
Learn more

EDUCATION

Allergy & ENT: Wait, Wait Don't Tell Me!, presented at the AAO-HNSF 2020 by Keith Andrew Sale, MD, Alpen A. Patel, MD, Glen Porter, MD, and Wesley D. Vander Ark, MD can be viewed here. It will be avialable through Friday, October 30, 2020.

Register Today for the 2020 AAOA Annual Meeting to earn up to 18.25 AMA PRA Category 1 Credit(s)TM for the live activity plus 8.75  AMA PRA Category 1 Credit(s)TM for the on demand content.

PLEASE ALLOW 24-48 HOURS FOR YOUR REGISTRATION TO BE PROCESSED FOR YOU TO RECEIVE THE LOGIN/ACCESS INSTRUCTIONS.

For those member and nonmembers who register for the AAOA 2020 Annual Meeting Oct 24-29 (live stream) before October 15th, you will be offered complimentary registration to participate in the AAO-HNSF “Comprehensive Otolaryngology Week” component of the AAO-HNSF 2020 Virtual Annual Meeting & OTO Experience. Access to the Comprehensive week – Each registrant will receive a welcome email with login instructions once the AAOA Annual Meeting Registration list is imported. The deadline to register to get the access is October 15th.

IFAR

IFAR Impact Factor: 2.454

aaoaf-ifar

IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More

Now Available

Changes in Managing Practices

Mission

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices.

Read More

Live and Online CME

New Year, Same Pandemic
January 25-March 25 | On-Demand
Learn More and Register

Just the Basics
January 25-March 25 | On-Demand
Learn More and Register

USP 797 Online Module
Learn More and Register

2021 Basic Course in Allergy & Immunology
July 15-17 | Seattle, WA

2021 AAOA Annual Meeting

News and Updates

Today In ENT Allergy: AAOA’s Podcast. Episode 3 –Allergy in Your ENT Practice

In the third episode of the AAOA’s NEW podcast series Today in ENT Allergy: AAOA’s…

read more

Allergic Reactions Related to Covid-19 Vaccinations in Allergic Patients

Joint Statement by the American Academy of Otolaryngology–Head and Neck Surgery (AAO–HNS) and the American…

read more
College Allergy Symptoms Treatment Back to Shcool

PRACTICE RESOURCES

AAOA Practice Resource Tool Kit

The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.

Read More

PATIENT CORNER

Menu

Practice Resources

Ingestion Challenge Testing

peanuts-2163043_640

Ingestion Challenge Testing Update 2013

Previously ingestion challenge testing for food, drugs or other substance was reported under Code 95075. That code has been deleted and effective January 1, 2013 is replaced by two new codes 95076 and 95079.

Code 95076 is defined as Ingestion challenge test (sequential and incremental ingestion of test items, e.g., food, drug or other substance); initial 120 minutes of testing.

Code 95079 is an add on code always reported with Code 95076 and is defined as each additional minutes of testing (list separately in addition to code for primary procedure.

As an example for the use of the new codes for drug allergy testing, consider a common protocol for penicillin allergy testing.  An initial single prick test is performed with each of the following: histamine, saline, benzylpenicilloyl polylysine (Pre-Pen), and penicillin G.

If these tests are “negative”, intradermal tests are then performed in the following manner: one intradermal application of a saline control, and two intradermal injections each for benzylpenicilloyl polylysine and penicillin G.

If the intradermal tests are “negative”, then on oral challenge with a penicillin product is given, and the patient is observed for one hour. The physician should bill for 9 units of 95018 (4 prick and 5 intradermal tests), and 1 unit of 95076 for the oral challenge test.

A Member Benefit

Allergy and Rhinology Journal (IFAR)

The International Forum of Allergy & Rhinology (IFAR) is the official journal of the AAOA and the American Rhinologic Society (ARS). Published monthly by John Wiley & Sons, Inc., IFAR provides a forum for clinical researchers, basic scientists, clinicians, and others to publish original research and explore controversies in the medical and surgical treatment of patients with otolaryngic allergy, rhinologic, and skull base conditions.

President Mims Message

April 2017

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices. Read More

News

New Articles from IFAR

Safety of long-term Intranasal Budesonide

The aim of this study was to determine the impact of long-term topical budesonide treatment via the mucosal atomization device (MAD) on the hypothalamic-pituitary-adrenal axis (HPAA) and intraocular pressure (IOP).. Read More

Medical therapy for Chronic Rhino-sinusitis

The indications for surgical management of chronic rhinosinusitis (CRS) in patients with cystic fibrosis (CF) are poorly defined..
Read More

New Blog Posts

Posts from AAOA Leaders

Allergies, not just for summer anymore. Read More

How to treat allergies at home.
Read More